European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 30, Status: Authorised

Submitted by Anonymous (not verified) on 9 June 2026 - 10:16

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 8 June 2026 - 16:08

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 24, Status: Authorised

Submitted by Anonymous (not verified) on 8 June 2026 - 16:04

Human medicines European public assessment report (EPAR): Yescarta, axicabtagene ciloleucel, Date of authorisation: 23/08/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 18, Status: Authorised

Submitted by Anonymous (not verified) on 8 June 2026 - 15:52

Human medicines European public assessment report (EPAR): Alecensa, alectinib, Date of authorisation: 16/02/2017, Revision: 18, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More